日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer

一项随机II期研究比较了帕博利珠单抗联合放化疗同步给药与序贯给药治疗局部晚期头颈癌的疗效

Zandberg, Dan P; Vujanovic, Lazar; Clump, David A; Isett, Brian P; Wang, Hong; Sica, Gabriel; Bao, Riyue; Li, Housayin; Ohr, James; Skinner, Heath D; Seethala, Raja R; Chiosea, Simion I; Ferris, Robert L; Bauman, Julie E

Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)

一项针对鳞状非小细胞肺癌患者的berzosertib、卡铂、吉西他滨和帕博利珠单抗的Ib期研究(ETCTN 10313)

Villaruz, Liza C; Schluger, Benjamin; Wang, Hong; Ohr, James; Petro, Daniel; Fuld, Alexander D; Herzberg, Benjamin; Dawar, Richa; Nieva, Jorge; Ruiz, Jimmy; Christner, Susan M; Holleran, Julianne L; Bakkenist, Christopher J; Gore, Steven; Beumer, Jan H

Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit

可手术头颈癌患者接受新辅助靶向治疗后,生存获益显著

Mascarella, Marco A; Olonisakin, Tolani F; Rumde, Purva; Vendra, Varun; Nance, Melonie A; Kim, Seungwon; Kubik, Mark W; Sridharan, Shaum S; Ferris, Robert L; Fenton, Moon J; Clayburgh, Daniel R; Ohr, James P; Joyce, Sonali C; Sen, Malabika; Herman, James G; Grandis, Jennifer R; Zandberg, Dan P; Duvvuri, Umamaheswar

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

纳武利尤单抗联合放化疗治疗中高危局部晚期头颈部鳞状细胞癌的安全性:RTOG基金会3504

Gillison, Maura L; Ferris, Robert L; Harris, Jonathan; Colevas, A Dimitrios; Mell, Loren K; Kong, Christina; Jordan, Richard C; Moore, Kevin L; Truong, Minh-Tam; Kirsch, Claudia; Chakravarti, Arnab; Blakaj, Dukagjin M; Clump, David A; Ohr, James P; Deeken, John F; Gensheimer, Michael F; Saba, Nabil F; Dorth, Jennifer A; Rosenthal, David I; Leidner, Rom S; Kimple, Randall J; Machtay, Mitchell; Curran, Walter J Jr; Torres-Saavedra, Pedro; Le, Quynh Thu

Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer

西妥昔单抗、放射疗法和伊匹木单抗治疗局部晚期头颈癌的I期临床试验

Ferris, Robert L; Moskovitz, Jessica; Kunning, Sheryl; Ruffin, Ayana T; Reeder, Carly; Ohr, James; Gooding, William E; Kim, Seungwon; Karlovits, Brian J; Vignali, Dario A A; Duvvuri, Umamaheswar; Johnson, Jonas T; Petro, Daniel; Heron, Dwight E; Clump, David A; Bruno, Tullia C; Bauman, Julie E

Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis

针对伴有远处转移的头颈部鳞状细胞癌的根治性局部治疗

Borson, Steven; Shuai, Yongli; Branstetter, Barton F; Nilsen, Marci Lee; Hughes, Marion A; Fenton, Moon; Kubik, Mark; Sridharan, Shaum; Clump, David A; Skinner, Heath D; Johnson, Jonas T; Chiosea, Simion I; Ohr, James; Duvvuri, Umamaheswar; Kim, Seungwon; Traylor, Katie S; Ferris, Robert; Zandberg, Dan P

A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients

一项II期前瞻性试验,旨在评估光生物调节疗法在局部晚期头颈癌患者治疗中限制口腔黏膜炎的疗效

Taylor, Janielle K-A; Mady, Leila J; Baddour, Khalil; Iheagwara, Uzoma K; Zhai, Shuyan; Ohr, James P; Zandberg, Daniel P; Gorantla, Vikram C; Ferris, Robert L; Kim, Seungwon; Duvvuri, Umamaheswar; Kubik, Mark W; Sridharan, Shaum; Johnson, Jonas T; Holeva, Karen D; Quinn, Annette E; Clump, David A

A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival

胰腺癌多学科诊疗中心消除治疗中的社会经济差异,提高患者生存率

Hoehn, Richard S; Rieser, Caroline J; Winters, Sharon; Stitt, Lauren; Hogg, Melissa E; Bartlett, David L; Lee, Kenneth K; Paniccia, Alessandro; Ohr, James P; Gorantla, Vikram C; Krishnamurthy, Anuradha; Rhee, John C; Bahary, Nathan; Olson, Adam C; Burton, Steve; Ellsworth, Susannah G; Slivka, Adam; McGrath, Kevin; Khalid, Asif; Fasanella, Kenneth; Chennat, Jennifer; Brand, Randal E; Das, Rohit; Sarkaria, Ritu; Singhi, Aatur D; Zeh, Herbert J; Zureikat, Amer H

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer.

菲克拉妥珠单抗和西妥昔单抗治疗西妥昔单抗耐药、复发/转移性头颈癌的 I 期研究

Bauman Julie E, Ohr James, Gooding William E, Ferris Robert L, Duvvuri Umamaheswar, Kim Seungwon, Johnson Jonas T, Soloff Adam C, Wallweber Gerald, Winslow John, Gaither-Davis Autumn, Grandis Jennifer R, Stabile Laura P

Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer

接受立体定向放射治疗的复发性、既往接受过放射治疗的头颈癌患者长期生活质量评价

Thomas, Joel; Wang, Hong; Clump, David A; Ferris, Robert L; Duvvuri, Umamaheswar; Ohr, James; Heron, Dwight E